Matthew Rehmann, Ph.D. is a Senior Scientist at Bristol Myers Squibb (BMS) in the Upstream Bioprocess Development department in Devens, MA. He has expertise in PAT for cell culture systems with a focus on Raman spectroscopy. He received his PhD in Chemical Engineering from the University of Delaware in 2016.